You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
NEW YORK – Janssen Pharmaceutical on Monday said it has begun a rolling submission of its biologics license application for the multiple myeloma CAR T-cell therapy ciltacabtagene autoleucel (cilta-cel) with the US Food and Drug Administration.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?Register for Free.